Redesigning obesity trials for a chronic disease era
For much of its history, obesity research has occupied an awkward space within clinical development. Too medical to dismiss outright, yet, too entangled with lifestyle narratives to command the same seriousness as closely linked conditions like cardiovascular disease or diabetes, it has often been studied through a narrow lens – short trials, blunt endpoints, and a lingering assumption that weight loss alone was the outcome that mattered.
Industry Events & Conferences
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
Capital Markets Day 2026
The event will provide investors with a deeper understanding of hVIVO's strategic evolution from specialist human ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
PSI 2026
Join us at the PSI 2026 Conference, taking place 15–17 June at the award‑winning ICC Belfast. This year’s event brings ...
PCMG26
PCMG26 is a leading annual gathering for professionals in pharmaceutical clinical outsourcing, vendor management, and ...
BIO International Convention
hVIVO is proud to be attending BIO International Convention 2026, the world’s largest gathering of biotechnology, ...
American Society for Virology
The American Society for Virology (ASV) is a premier scientific organisation dedicated to advancing the understanding ...
Options XIII
Options XIII is a major global conference dedicated to advancing influenza science, policy, and pandemic preparedness, ...
ERS Congress
The ERS International Congress is one of the world’s leading events in respiratory medicine, bringing together ...
World Vaccine Congress Europe
Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress ...
BIO-Europe 2026
Connect with the Right Partners to Accelerate Biopharma Growth hVIVO will be attending BIO-Europe, the leading ...
Dutch Life Sciences Conference 2026
Connect with Europe’s Leading Life Sciences Ecosystem hVIVO will be attending the Dutch Life Sciences Conference, a key ...
Hands On Workshops
Workshop: Build Your Target Product Profile With Confidence
Build your Target Product Profile With Confidence For biotech and start‑up teams balancing innovation with speed, a ...
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
A case-based, interactive workshop designed to equip participants with the tools needed to navigate the path to ...
On-Demand Education
Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
Watch on demand here. As infectious disease programs face increasing pressure to generate high-quality data faster, ...
The future of cardiometabolic trials: From obesity to outcomes that matter
As obesity continues to reshape the cardiometabolic landscape, early-stage developers face growing pressure to generate ...
.jpg)
Accelerate your RSV Programme with our RSV Human Challenge Model
About RSV & why developing RSV antivirals and vaccines are critical Respiratory Syncytial Virus (RSV) is a common, ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Technical Due Diligence in Drug Development: What Startup Founders Need to Know to Succeed
Join industry experts for an interactive discussion on mastering technical due diligence. Due diligence is a critical ...
News & Resources
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes
Selecting the Right Endpoints for Early-Phase Cardiometabolic Trials
The role of incretin receptor agonists in the treatment of obesity
Rethinking Early-Phase Cardiometabolic Drug Development
Retrospective analysis of glomerular filtration rate estimated using different equations with and without adjustment to individual body surface area
Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening
Dermatology Therapies: How Early-Phase Clinical Infrastructure Shapes Success
Real‑World RSV Maternal Vaccine Data Marks a Turning Point for Infant Protection
A Landmark Moment for Pertussis Vaccine Development — and for the Future of Bacterial Challenge Models